IART
Integra LifeSciences Holdings Corporation · Healthcare
Insiders bought $102K of Integra LifeSciences Holdings Corporation in the last 12 months
1 insider bought on 1 day.
IART over the last year
Largest buyers, last 12 months
IART after insider buys
3 months after each buy, from the first price a copier could get.
5 buys since 2017 with 3 months of prices.
Congress
Members reported 5 trades in IART since 2023.
Every filing
119 insider filings since 2016, newest first
Jeffrey A Graves · Director
Jeffrey Mosebrook · SVP, Fin, Princ Acct Officer
Stuart Essig · Exec. COB
Barbara B Hill · Director
Robert T. Davis Jr. · EVP, Pres, TT
Jeffrey Mosebrook · SVP, Fin, PAO
Eric Schwartz · EVP, GC, Sec
Witte Jan De · President and CEO
Michael J. Mcbreen · EVP, Pres, CSS
Robert T. Davis Jr. · EVP, Pres, TT
Lisa Evoli · EVP and CHRO
Lisa Evoli · EVP and CHRO
Raymond G. Murphy · Director
Lisa Evoli · EVP and CHRO
Glenn Coleman · EVP and COO
Tru St Partnership, L.P. · 10% owner
Tru St Partnership, L.P. · 10% owner
Jeffrey Mosebrook · SVP, Fin, Princ Acct Officer
Michael J. Mcbreen · EVP, Pres, CSS
Glenn Coleman · EVP and COO
Tru St Partnership, L.P. · 10% owner
Peter J Arduini · President and CEO
Michael J. Mcbreen · EVP, Pres, CSS
Raymond G. Murphy · Director
Lisa Evoli · EVP and CHRO
Glenn Coleman · EVP and COO
Glenn Coleman · EVP and COO
Lisa Evoli · EVP and CHRO
Glenn Coleman · EVP and COO
Glenn Coleman · EVP and COO
Tru St Partnership, L.P. · 10% owner
Stuart Essig · Director
Jeffrey Mosebrook · SVP, Fin, Princ Acct Officer
Michael J. Mcbreen · EVP, Pres, CSS
Eric Schwartz · EVP, GC, Sec
Eric Schwartz · EVP, GC, Sec
Robert T. Davis Jr. · EVP, Pres, TT
Peter J Arduini · President and CEO
Tru St Partnership, L.P. · 10% owner
Peter J Arduini · President and CEO
Glenn Coleman · EVP and COO
Raymond G. Murphy · Director
Glenn Coleman · EVP and COO
Michael J. Mcbreen · EVP, Pres, CSS
Lisa Evoli · EVP and CHRO
Tru St Partnership, L.P. · 10% owner
Jeffrey Mosebrook · SVP, Fin, Princ Acct Officer
Glenn Coleman · EVP and COO
Richard E Caruso · 10% owner
Lisa Evoli · CHRO
About Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.